http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-046870-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C219-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-68
filingDate 2004-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d43c7dcc2657e38fcfefdf6afa48cbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac5cd8a5b4e44a5c68d591543bfd0fd5
publicationDate 2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-046870-A1
titleOfInvention DERIVATIVES OF TETRAHYDRONAFTALENO AS ACTIVATING LINKS OF RAR RECEPTORS, THEIR USE IN HUMAN MEDICINE AS WELL AS COSMETICS AND PHARMACEUTICAL AND COSMETIC PREPARATIONS CONTAINING THEM.
abstract Pharmaceutical compositions intended for use in human or veterinary medicine, or even in cosmetic compositions, with action of activating ligands of the RAR receptors. Claim 1: Compounds characterized in that they respond to formula (1), in which: Ar represents a radical chosen from the radicals of the group of formulas (2); R1 represents a radical -OR3 or -NR4R5, R3, R4, and R5 have the meanings given below; R2 represents a hydrogen, fluorine, chlorine atom, a methyl radical or an OR6 radical, R6 has the meanings given below; R3 represents a hydrogen atom, a linear or branched C1-20 alkyl radical, a C1-20 mono- or polyhydroxyalkyl radical, a C1-20 monoaminoalkyl radical, or a sugar residue; R4, R5, identical or different, represent a hydrogen atom, a hydroxy radical, a C1-6 alkyl radical, linear or branched, a mono- or polyhydroxyalkyl C1-20 radical, or R4 and R5 form with the nitrogen of the structure generally, an amino acid residue or a peptide residue, or R4 and R5 taken together, form a heterocycle; R6 represents a hydrogen atom, a methyl radical or an acetyl radical; R7 represents a CF3 or methyl radical; r ', r' ', identical or different, represent a hydrogen atom, a linear or branched C1-4 cyclic alkyl radical, a radical (C = O) R7, or, r', r '' taken in the form together, they form a heterocycle pyrrolidine or piperidine, R7 has the above meanings; A represents an oxygen atom or a sulfur atom; n is an integer between 1 and 4; W represents a radical -CH2-; Y represents an oxygen atom or a sulfur atom, and the salts of the compounds of formula (1) when R1 represents an OH function, as well as the optical and geometric isomers of said compounds of formula (1).
priorityDate 2003-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297

Total number of triples: 53.